Kolkata News Today

Listeriosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

 Breaking News
  • No posts were found

Listeriosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

December 01
14:35 2022
Listeriosis  Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
DelveInsight Business Research LLP
DelveInsight’s “Listeriosis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Listeriosis, historical and forecasted epidemiology as well as the Listeriosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s Listeriosis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Listeriosis, historical and forecasted epidemiology as well as the Listeriosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Listeriosis market report provides current treatment practices, emerging drugs, Listeriosis market share of the individual therapies, and current and forecasted Listeriosis market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Listeriosis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market

 

Some of the Key Facts of the Listeriosis Market Report:

 

  • Listeriosis is a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes. An estimated 1,600 people get listeriosis each year, and about 260 die.

  • Listeria monocytogenes is an uncommon human pathogen. It is mostly identified through cases of invasive disease, either associated with outbreaks or as sporadic infections, and through food safety programs. Nonperinatal cases of invasive listeriosis have an estimated worldwide incidence ranging from 0.1–1.1 cases per 105 population. CNS infections are present, on average, in 47% of infected patients with an average case-fatality rate of 36%). 

 

  •  The USDA issued 333 food recalls in the 5-year period from 2002 to 2006, 108 (32.4%) of which were due to L. monocytogenes. The quantity of meat and poultry involved ranged from 5 lbs (c. 2 kg) to 27 400 000 lbs (12 454 545 kg) per recall with a median of 1100 lbs (500 kg) per event. By comparison, the FDA issued 126 food product recalls or alerts in 2006 alone, 19 (15%) of which were due to L. monocytogenes. In these instances, bacteria were isolated from a diverse array of products including dairy (cheeses, raw milk), agricultural (strawberries, cut fresh fruit, sliced mushrooms), and various ready-to-eat foodstuffs such as coleslaw, crab dip, smoked salmon and turkey, egg salad, potato salad, and macaroni salad. The most commonly isolated bacteria belong to the serotypes 4b, 1/2a and 1/2b 

 

Key Benefits of the Listeriosis Market Report

 

  • The report covers the descriptive overview of Listeriosis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

  • Comprehensive insight has been provided into the Listeriosis epidemiology and treatment in the 7MM

  • Additionally, an all-inclusive account of both the current and emerging therapies for Listeriosis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

  • A detailed review of Listeriosis market; historical and forecasted is included in the report, covering drug outreach in the 7MM

  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Listeriosis market

 

Got queries? Click here to know more about the Listeriosis Market Landscape

 

Listeriosis Overview

Listeriosis is a serious infection usually caused by eating food contaminated with the bacterium Listeria monocytogenes. An estimated 1,600 people get listeriosis each year, and about 260 die. The infection is most likely to sicken pregnant women and their newborns, adults aged 65 or older, and people with weakened immune systems. Listeriosis is usually diagnosed when a bacterial culture (a type of laboratory test) grows Listeria from body tissue or fluid, such as blood, spinal fluid, or the placenta. Invasive illness: People with an invasive illness are treated with antibiotics. Learn more about the treatment of people who have an invasive illness or who have a greater chance of developing one. Most people recover from intestinal illness without antibiotic treatment. Antibiotics are needed only for patients who are very ill or at risk of becoming very ill. People who have an intestinal illness should drink extra fluids when they have diarrhea.

Listeriosis Epidemiological Insights:

 

  •  137 (7.23%) of these samples were L. monocytogenes positive. The prevalence of L. monocytogenes in the animal samples was high (32.1%), and the main environmental source of prevalent genotypes in the three farms was silage. 

Listeriosis Epidemiological Segmentation 

  • Total Listeriosis prevelant cases 

  • Total Listeriosis diagnosed Cases 

  • Total Listeriosis treatment cases 

Listeriosis Market Outlook 

The Listeriosis market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Listeriosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

 

This segment gives a thorough detail of the Listeriosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

According to DelveInsight, the Listeriosis market in 7MM is expected to change in the study period 2019-2032.

 

Learn more by requesting for sample @ Listeriosis Market Landscape

Table of Contents

 

  1.   Key Insights 

  2.   Report Introduction 

  3.   Executive Summary of Listeriosis  

  4.   Disease Background and Overview

  5.   Epidemiology and patient population

  6.   The United States 

  7.   EU 5

  8.   Listeriosis   Emerging Therapies

  9.   Listeriosis  Market Outlook

  10.   Market Drivers 

  11.   Market Barriers 

  12.   Market Access and Reimbursement of Therapies

  13.   Appendix

  14.   Listeriosis   Report Methodology

  15.   DelveInsight Capabilities

  16.   Disclaimer

  17.   About DelveInsight

Click here to read more about Listeriosis Market Landscape

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Adya Kaul
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/